- 関
- angiogenic inhibitor、antiangiogenic agent
WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
- not in favor of (an action or proposal etc.)
- a person who is opposed (to an action or policy or practice etc.); "the antis smelled victory after a long battle"
- social insect living in organized colonies; characteristically the males and fertile queen have wings during breeding season; wingless sterile females are the workers (同)emmet, pismire
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
- 《話》(特定の慣習・政策・行動などに)反対する人
- 『アリ』
- =ain't
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. Pure red cell aplasia due to anti-erythropoiesis-stimulating agent antibodiespure red cell aplasia due to anti erythropoiesis stimulating agent antibodies [show details]
… are becoming increasingly available around the world; treatment with these agents has also been associated with development of anti-EPO both non-neutralizing and neutralizing antibodies, with a notable outbreak …
- 2. 血管新生阻害剤の概要overview of angiogenesis inhibitors [show details]
…delivery of chemotherapeutic agents to the tumor cells. It is possible that this mechanism predominates at intermediate levels of VEGF inhibition, while more classical anti-angiogenic mechanisms may predominate …
- 3. 腎細胞癌治療の概要overview of the treatment of renal cell carcinoma [show details]
…who have progressed following an initial VEGF targeted agent and immunotherapy may benefit from treatment with an alternative anti-angiogenic agent. These could include axitinib, cabozantinib, or lenvatinib …
- 4. 癌生存者における口腔の衛生状態oral health in cancer survivors [show details]
…treated with or have been treated in the past with bone-modifying agents (ie, bisphosphonates or denosumab) or anti-angiogenic agents (ie, bevacizumab) are at risk for developing osteonecrosis of the jaw …
- 5. 手術不能な転移性大腸癌に対する全身化学療法：治療に関する推奨systemic chemotherapy for nonoperable metastatic colorectal cancer treatment recommendations [show details]
… an anti-VEGF agent, and (if RAS and BRAF wild type) an anti-EGFR agent and who require additional therapy, single-agent regorafenib or trifluridine-tipiracil… inhibitor of angiogenic tyrosine kinases (including the VEGF receptors 1 to 3), as well as other membrane and intracellular kinases. Trifluridine-tipiracil (TAS-102), an oral cytotoxic agent that consists…
English Journal
- Structural characterization and effect on anti-angiogenic activity of a fucoidan from Sargassum fusiforme.
- Cong Q1, Chen H1, Liao W1, Xiao F1, Wang P1, Qin Y1, Dong Q2, Ding K3.
- Carbohydrate polymers.Carbohydr Polym.2016 Jan 20;136:899-907. doi: 10.1016/j.carbpol.2015.09.087. Epub 2015 Oct 9.
- A fucoidan FP08S2 was isolated from the boiling-water extract of Sargassum fusiforme, purified by CaCl2 precipitation and chromatography on DEAE-cellulose and Sephacryl S-300. FP08S2 contained fucose, xylose, galactose, mannose, glucuronic acid, and 20.8% sulfate. The sulfate groups were attached to
- PMID 26572427
- Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy.
- Kim J1, Lee YM2, Kim H1, Park D1, Kim J2, Kim WJ3.
- Biomaterials.Biomaterials.2016 Jan;75:102-11. doi: 10.1016/j.biomaterials.2015.10.022. Epub 2015 Oct 14.
- We present a cationic polymer architecture composed of phenylboronic acid (PBA), sugar-installed polyethylenimine (PEI), and polyethylene glycol (PEG). The chemical bonding of PBA with the diol in the sugar enabled the crosslinking of low-molecular-weight (MW) PEI to form high-MW PEI, resulting in s
- PMID 26491998
- Anti-heparanase activity of ultra-low-molecular-weight heparin produced by physicochemical depolymerization.
- Achour O1, Poupard N1, Bridiau N1, Bordenave Juchereau S1, Sannier F1, Piot JM1, Fruitier Arnaudin I1, Maugard T2.
- Carbohydrate polymers.Carbohydr Polym.2016 Jan 1;135:316-23. doi: 10.1016/j.carbpol.2015.08.041. Epub 2015 Aug 20.
- Heparanase is an endo-β-D-glucuronidase that plays an important role in cancer progression, in particular during tumor angiogenesis and metastasis. Inhibiting this enzyme is considered as one of the most promising approaches in cancer therapy. Heparin is a complex glycoaminoglycan known as a strong
- PMID 26453883
Japanese Journal
- 肺がん治療における血管新生阻害薬 (特集 肺がんの個別化医療)
- Industrial Info. 血管新生阻害剤ラムシルマブ(消化器癌開発)
- Quantification of (−)-epigallocatechin-3-gallate Inhibition of Migration and Invasion of Oral Squamous Cell Carcinoma Cell Lines Using Real-time Cell Analysis
- The Showa University Journal of Medical Sciences 27(2), 71-81, 2015
- NAID 130005110364
Related Links
- Disclosed is a composition having an anti-angiogenic activity, which is safe even when ingested for a long period, and can exert a prophylactic or therapeutic effect on a disease associated with angiogenesis to a satisfactory level even ...
- Table 1. Comparison of current antiangiogenic agents being used or investigated in GI malignancies. Anti- Mechanism of Tumour Sites Toxicities from dose finding studies angiogenic Action of ...
★リンクテーブル★
[★]
- 英
- angiogenic inhibitor、anti-angiogenic agent
- 関
- 血管新生阻害剤、血管新生抑制因子、血管新生抑制剤、血管新生抑制物質、血管新生抑制薬、抗血管新生薬
- 血管内皮増殖因子 VEGF
[show details]
薬理学
[★]
- 英
- angiogenic inhibitor、anti-angiogenic agent
- 関
- 血管新生抑制因子、血管新生抑制剤、血管新生抑制物質、血管新生阻害薬、血管新生抑制薬、抗血管新生薬
[★]
- 関
- angiogenesis inhibitor、anti-angiogenic agent、antiangiogenic agent
[★]
- 英
- antiangiogenic agent、anti-angiogenic agent
- 関
- 血管新生阻害剤、血管新生阻害物質、血管新生抑制物質、血管新生阻害薬、血管新生抑制薬
[★]
- 関
- angiogenesis inhibitor、angiogenic inhibitor、anti-angiogenic agent
[★]
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
[★]
- 関
- angiogenesis、angiogenetic、angioneogenesis、angioplasty、haematogenous、hematogenic、hematogenous、hematogenously、neoangiogenesis、neovascularisation、neovascularization、vascularization、vasculogenesis、vasculogenic、vasogenic
[★]
- 関
- aged、ageing、aging、year old
[★]
- 同
- ants, stinging
[★]